Positions

Selected Publications

Academic Article

Year Title Altmetric
2020 Biologic Switching among Non-Systemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry.Journal of Rheumatology2020
2020 Alagille Syndrome and Chronic Arthritis: An International Case SeriesJournal of Pediatrics.  218:228-230.e1. 2020
2020 Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic LymphohistiocytosisArthritis and Rheumatology.  72:326-334. 2020
2019 Making Decisions About Stopping Medicines for Well-Controlled Juvenile Idiopathic Arthritis: A Mixed-Methods Study of Patients and Caregivers.Arthritis Care and Research2019
2019 Characteristics of coexisting localized scleroderma and inflammatory arthritis.European Journal of Rheumatology.  1-5. 2019
2019 Establishing an updated core domain set for studies in juvenile idiopathic arthritis: A report from the OMERACT 2018 JIA workshopJournal of Rheumatology.  46:1006-1013. 2019
2018 Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature 2018
2018 Aortitis With an Aneurysm at Initial Presentation of Crohn Disease.Journal of Pediatric Gastroenterology and Nutrition.  67:e12-e13. 2018
2018 Aortitis with an Aneurysm at Initial Presentation of Crohn DiseaseJournal of Pediatric Gastroenterology and Nutrition.  67:e12-e13. 2018
2018 Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitorsAnnals of the Rheumatic Diseases.  77:1012-1016. 2018
2018 Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: A comparative study of children with and without juvenile idiopathic arthritis 2018
2017 Evidence for updating the core domain set of outcome measures for juvenile idiopathic arthritis: Report from a special interest group at OMERACT 2016Journal of Rheumatology.  44:1884-1888. 2017
2017 Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: A retrospective study 2017
2017 Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United StatesArthritis and Rheumatology.  69:1733-1740. 2017
2016 The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis 2016
2016 Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients 2016
2016 Ustekinumab as a Therapeutic Option for Children with Refractory Enthesitis-Related Arthritis 2016
2014 Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitorsJournal of Rheumatology.  41:2078-2084. 2014
2014 Risk of malignancy associated with biologic agents in pediatric rheumatic diseaseCurrent Opinion in Rheumatology.  26:538-542. 2014
2013 Brief report: Incidence of selected opportunistic infections among children with juvenile idiopathic arthritisArthritis and Rheumatism.  65:1384-1389. 2013
2013 What is the background incidence of malignancy in children with rheumatic disease?Current Rheumatology Reports.  15. 2013
2012 Intensive care requirement, rather than degree of serum ferritin elevation, predicts mortality in macrophage activation syndromePediatric Critical Care Medicine.  13:616. 2012
2011 Brain cavernomas associated with en coup de sabre linear scleroderma: Two case reports 2011
2011 Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter seriesArthritis and Rheumatism.  63:545-555. 2011
2011 Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: Case report and a review of the pediatric autoimmune pancreatitis literature 2011

Chapter

Year Title Altmetric
2018 Diskitis.  302-303. 2018
2018 Spondyloarthropathy.  872-873. 2018

Research Overview

  • My primary research interests are in epidemiologic analysis related to juvenile idiopathic arthritis (JIA). Specifically I am interested in the use of medications to treat JIA, the outcomes of JIA in adulthood, and the comparative effectiveness of treatment modalities.
  • Education And Training

  • Doctor of Medicine, Eastern Virginia Medical School 2008
  • UAB/Children's of Alabama, Residency 2011
  • UAB/Children's of Alabama, Postdoctoral Fellowship 2014
  • Full Name

  • Melissa Mannion